The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Ciltacabtagene autoleucel, a B-cell maturation antigen (BCMA)-directed chimeric antigen receptor T-cell (CAR-T) therapy, in relapsed/refractory multiple myeloma (R/R MM): Updated results from CARTITUDE-1.
 
Saad Zafar Usmani
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Merck; Seagen; Skyline Diagnostics; Takeda
Speakers' Bureau - Amgen; Celgene; Janssen Oncology; Sanofi; Takeda
Research Funding - Amgen; Array BioPharma; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Merck; Pharmacyclics; Sanofi; Seagen; Skyline Diagnostics
 
Jesus G. Berdeja
Consulting or Advisory Role - Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); crispr therapeutics (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Kite, a Gilead company (Inst); Legend Biotech (Inst); Secura Bio (Inst); SERVIER (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); Acetylon Pharmaceuticals (Inst); Amgen (Inst); Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celularity (Inst); Constellation Pharmaceuticals (Inst); crispr therapeutics (Inst); CURIS (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Glenmark (Inst); Ichnos Sciences (Inst); Janssen (Inst); Kesios Therapuetics (Inst); Lilly (Inst); Novartis (Inst); poseida therapeutics (Inst); Sanofi (Inst); Takeda (Inst); Teva (Inst); Vivolux (Inst)
 
Deepu Madduri
Honoraria - Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Kinevant; Legend Biotech; Sanofi; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Kinevant; Legend Biotech; Sanofi; Takeda
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Regeneron
 
Andrzej J. Jakubowiak
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Juno Therapeutics; Karyopharm Therapeutics; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Juno Therapeutics; Karyopharm Therapeutics; Sanofi
 
Mounzer E. Agha
No Relationships to Disclose
 
Adam D. Cohen
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Celgene; Genentech/Roche; GlaxoSmithKline; Janssen; Takeda
Patents, Royalties, Other Intellectual Property - Novartis
 
Parameswaran Hari
Honoraria - Abbvie/Pharmacyclics; Amgen; BMS; GlaxoSmithKline; Incyte; Janssen Oncology; Karyopharm Therapeutics; Kite, a Gilead company; Novartis; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Janssen; Karyopharm Therapeutics; Kite, a Gilead company; Pharmacyclics; Sanofi; Takeda
Research Funding - Celgene (Inst); Millennium (Inst); Onyx (Inst); Spectrum Pharmaceuticals (Inst)
 
Tzu-Min Yeh
Employment - Janssen
 
Yunsi Olyslager
No Relationships to Disclose
 
Arnob Banerjee
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Carolyn Chang Jackson
Employment - Janssen Research & Development
Consulting or Advisory Role - Memorial Sloan-Kettering Cancer Center
 
Alicia Jones Allred
Employment - Johnson & Johnson/Janssen
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
 
Enrique Zudaire
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
Patents, Royalties, Other Intellectual Property - Patents pending with Janssen
Travel, Accommodations, Expenses - Janssen Research & Development
 
William Deraedt
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Xiaoling Wu
Employment - Legend Biotech
Stock and Other Ownership Interests - Bristol-Myers Squibb; Editas Medicine; Legend Biotech
Travel, Accommodations, Expenses - Legend Biotech
 
Marlene Carrasco-Alfonso
Employment - Legend Biotech; Novartis
Stock and Other Ownership Interests - Abeona Therapeutics; Adaptimmune; Adverum; Akcea Therapeutics; Allogene Therapeutics; Alnylam; Arbutus Biopharma; Arrowhead Pharmaceuticals; Atara Biotherapeutics; Audentes Therapeutics; Legend Biotech; Novartis
 
Muhammad Akram
Employment - Legend Biotech
Stock and Other Ownership Interests - Legend Biotech
Research Funding - Legend Biotech
Travel, Accommodations, Expenses - Legend Biotech
Other Relationship - Legend Biotech
 
Yi Lin
Consulting or Advisory Role - Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Gamida Cell (Inst); Janssen Oncology (Inst); Juno Therapeutics (Inst); Kite/Gilead (Inst); Legend Biotech (Inst); Novartis (Inst); Sorrento Therapeutics (Inst); Vineti (Inst)
Research Funding - Bluebird Bio (Inst); Boston Scientific (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Janssen Oncology (Inst); Kite/Gilead (Inst); Merck (Inst); Takeda (Inst)
 
Thomas G. Martin
Consulting or Advisory Role - GlaxoSmithKline; Juno Therapeutics
Research Funding - AMGEN (Inst); Janssen Oncology; Janssen Oncology; Sanofi (Inst)
 
Sundar Jagannath
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen; Karyopharm Therapeutics; Legend Biotech; Sanofi; Takeda
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen; Karyopharm Therapeutics; Legend Biotech